about
Syndromic gastrointestinal stromal tumorsCurrent status of biomarker research in neurologyHypoxia signaling pathways: modulators of oxygen-related organellesMolecular characterizations of glioblastoma, targeted therapy, and clinical results to datePhysiological consequences of complex II inhibition for aging, disease, and the mKATP channelGenetically-defined metabolic reprogramming in cancerNovel therapeutic targets of tumor metabolismMetabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectIDH mutations in tumorigenesis and their potential role as novel therapeutic targets.Investigating mitochondrial redox state using NADH and NADPH autofluorescenceDeficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduriaPHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadMutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe EncephalopathyNo evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Generalized portrait of cancer metabolic pathways inferred from a list of genes overexpressed in cancerProtein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Visual gene-network analysis reveals the cancer gene co-expression in human endometrial cancerSomatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells.HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver.Genomic imprinting at a boundary element flanking the SDHD locusPolymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia.Mitochondria: key players in the neurotoxic effects of amphetamines.Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.Emerging insights into the molecular and cellular basis of glioblastoma.Underestimation of the Maximal Capacity of the Mitochondrial Electron Transport System in Oligomycin-Treated Cells.Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming.PARASITOID VENOM INDUCES METABOLIC CASCADES IN FLY HOSTSSAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditionsOXPHOS mutations and neurodegenerationDynamic changes in the gene expression profile during rat oral carcinogenesis induced by 4-nitroquinoline 1-oxideAn Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells
P2860
Q26738882-AF759B67-2D1B-4008-8F34-8B92D8A4BCFDQ26744505-10884C68-BEF2-4717-A7DE-9CF019A49512Q26799950-D6BE5EC6-4C1C-4F37-AED5-CF363DE5319DQ26822717-2219ED58-B536-4278-B35F-4A7559FF6D4BQ27002338-F1F507EF-03A8-4A5B-A210-9210419D7296Q27004739-9438BF5E-FCEE-4827-8A29-9982383B652DQ27005930-8A6A0E0A-A907-4B89-B01E-BE96668B8B3BQ27024293-82AB44AD-0E2D-414E-A378-46602DA6CB52Q27692015-C65EFC97-CAF9-466D-9863-0C3DC9110BA0Q28072889-4C2F6BEB-98F5-4776-859F-A76DD73DCDDBQ28288463-F41BDE93-6EE1-4BB0-865C-C6F3CBE888B9Q28296254-3D3508E2-2F61-4FB1-8B5C-CDCFB829807DQ28397132-D2D4FDC5-9498-4BE5-95D4-F235FD3FC210Q28975765-0AC2B769-B6A5-4FCF-8A63-D484DFD9C0BCQ30415944-8E49FAE3-0B1F-41DD-BAA1-1DDBA2FA6E91Q33608219-5FEC8287-BB18-4D55-9434-FF84CFEB870EQ34176623-6F2993A0-75D0-47CD-BE5E-B9120CB77E50Q34497888-375F086B-2596-4CE2-87FF-A4C14EDC61CBQ34525508-389D008B-926F-48F3-8139-B0D59DDAFC0BQ34586300-AD5EB582-B060-4EBA-ABF1-CAA8A2E35941Q34782086-F17E3A8A-81AA-40A5-9696-EFB30425E4E9Q34848256-D314A92F-E298-4CB6-ACE6-A2D8A8F22EA3Q35198043-A94668B9-77E0-4076-8D4D-7187A3346908Q35389568-8E593E18-045E-4101-AEE6-B009FBB7A177Q35500621-DA7EB6A2-C5AE-486D-B1DD-325CC7CE973DQ35524250-89B144A9-186D-4C75-8288-3CFF709E8D16Q35572468-B5DE8AC5-A3BF-4871-ADAF-4D5BC5A40285Q35666395-01EF4A60-17B5-4282-87CD-C82A2C52903DQ35914897-4A9B01F5-3F2C-4243-816C-A6E16DE8F929Q35947968-72BDDC39-3BD9-4277-A1D9-26B77F00DAF5Q36071323-940E2BBE-D002-493B-81C6-6A7C37523178Q36108056-FDAB186D-1688-4E59-B22F-F02F2CEC0575Q36198958-DD85940C-6B89-4E15-A514-129491255E16Q36480143-14F686B7-074A-4370-A8DC-9ABCC423CF1FQ36533623-85AC014A-2116-43DD-812E-DF8263A2A88AQ36624005-448B155E-7C09-4E49-8A7A-C9EDD3F22B0EQ36732789-3B560089-ECBD-4C58-B014-8020AD23E5C2Q36832167-CA3F252F-A0DD-4D3E-8889-7D6E57C1B80FQ36865610-C53B5127-349A-4B1B-9ADB-D55D477C00E3Q37093677-66331787-3D5D-4216-B905-D30746802BDA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Revisiting the TCA cycle: signaling to tumor formation
@en
Revisiting the TCA cycle: signaling to tumor formation.
@nl
type
label
Revisiting the TCA cycle: signaling to tumor formation
@en
Revisiting the TCA cycle: signaling to tumor formation.
@nl
prefLabel
Revisiting the TCA cycle: signaling to tumor formation
@en
Revisiting the TCA cycle: signaling to tumor formation.
@nl
P2093
P2860
P1476
Revisiting the TCA cycle: signaling to tumor formation
@en
P2093
Bora E Baysal
Gerald S Shadel
Nuno Raimundo
P2860
P304
P356
10.1016/J.MOLMED.2011.06.001
P577
2011-07-20T00:00:00Z